TDF-related compounds and analogs thereof

Details for Australian Patent Application No. 2005265098 (hide)

Owner Thrasos Therapeutics, Inc.

Inventors Sworin, Michael; Carlson, William D.; Keck, Peter C.; Bosukonda, Dattatreymurty

Agent Davies Collison Cave

Pub. Number AU-B-2005265098

PCT Pub. Number WO2006/009836

Priority 60/580,511 17.06.04 US; 60/610,054 15.09.04 US; 60/608,625 10.09.04 US; 60/618,735 14.10.04 US

Filing date 17 June 2005

Wipo publication date 26 January 2006

Acceptance publication date 23 February 2012

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

A61K 38/12 (2006.01) Medicinal preparations containing peptides - Cyclic peptides

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/009836 Priority application(s): WO2006/009836

23 February 2012 Application Accepted

  Published as AU-B-2005265098

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005265115-Methods and compositions for wound healing

2005265097-Separation of fluorous compounds